Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Targan

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Inflammatory Bowel Diseases|January 10, 2001
The role of chemokines and chemokine receptors in mucosal inflammationK A Papadakis, S R Targan
Expert Opinion on Pharmacotherapy|March 16, 2001
TNF-alpha antagonists for the treatment of Crohn's diseaseL Y Kam, S R Targan
Annual Review of Medicine|April 25, 2000
Role of cytokines in the pathogenesis of inflammatory bowel diseaseK A Papadakis, S R Targan
Current Opinion in Gastroenterology|October 7, 2006
Cytokine-based therapies in inflammatory bowel diseaseL Y Kam, S R Targan
Digestive Diseases and Sciences|March 1, 1988
New enema treatments for inflammatory bowel diseaseL C Karp, S R Targan
Critical Reviews in Immunology|January 1, 1996
Regulation of immune responses of the intestinal mucosaM T Abreu-Martin, S R Targan
Molecular Immunology|November 1, 1984
Immunobiological and immunochemical aspects of the T-200 family of glycoproteinsW Newman, S R Targan, L D Fast
Clinical and Experimental Immunology|January 1, 1991
Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cellsR L Deem, F Shanahan, S R Targan
Cellular Immunology|October 1, 1986
Active target cell processes, possibly involving receptor-mediated endocytosis, are critical for expression of cytotoxicity by natural killer cell-derived cytolytic factorR L Deem, A Niederlehner, S R Targan
Gastroenterology|July 1, 1989
Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn's diseaseP A Anton, S R Targan, F Shanahan
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Inflammatory Bowel Diseases|January 10, 2001
The role of chemokines and chemokine receptors in mucosal inflammationK A Papadakis, S R Targan
Expert Opinion on Pharmacotherapy|March 16, 2001
TNF-alpha antagonists for the treatment of Crohn's diseaseL Y Kam, S R Targan
Annual Review of Medicine|April 25, 2000
Role of cytokines in the pathogenesis of inflammatory bowel diseaseK A Papadakis, S R Targan
Current Opinion in Gastroenterology|October 7, 2006
Cytokine-based therapies in inflammatory bowel diseaseL Y Kam, S R Targan
Digestive Diseases and Sciences|March 1, 1988
New enema treatments for inflammatory bowel diseaseL C Karp, S R Targan
Critical Reviews in Immunology|January 1, 1996
Regulation of immune responses of the intestinal mucosaM T Abreu-Martin, S R Targan
Molecular Immunology|November 1, 1984
Immunobiological and immunochemical aspects of the T-200 family of glycoproteinsW Newman, S R Targan, L D Fast
Clinical and Experimental Immunology|January 1, 1991
Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cellsR L Deem, F Shanahan, S R Targan
Cellular Immunology|October 1, 1986
Active target cell processes, possibly involving receptor-mediated endocytosis, are critical for expression of cytotoxicity by natural killer cell-derived cytolytic factorR L Deem, A Niederlehner, S R Targan
Gastroenterology|July 1, 1989
Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn's diseaseP A Anton, S R Targan, F Shanahan
Pageof 12